Sex-associated differences in survival of patients undergoing resection for lung cancer Mark K Ferguson, MD, Jun Wang, MD, Philip C Hoffman, MD, Daniel.

Slides:

Advertisements

Similar presentations

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Advertisements

Elizabeth A. David, MD, David T

Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients Chi-Fu Jeffrey Yang, MD, Nicholas R. Mayne,

Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,

Gender differences in non–small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002 Antonio L Visbal, MD, Brent.

Leena Khaitan, MD, Francis P Sutter, Scott M Goldman, MD

Primary non-Hodgkin’s lymphoma of the lung

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non–Small Cell Lung Cancer: A Randomized, Double-Blind,

Quality of life after tailored combined surgery for stage I non–small-cell lung cancer and severe emphysema Eugenio Pompeo, MD, Enrico De Dominicis,

Joshua E. Rosen, BASc, Hari B

Trevor Williams, MD, MPH, Brian C

Validation of the Stage Groupings in the Eighth Edition of the TNM Classification for Lung Cancer Xizhao Sui, MD, Wei Jiang, MD, Haiqing Chen, MD, Fan.

Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B

Lung cancer staging and treatment in multidisciplinary trials: cancer and leukemia group B cooperative group approach1 Mark J Krasna, MD, Carolyn E Reed,

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng.

Heart Transplantation for the Failing Fontan

Surgery for coarctation of the aorta in infants weighing less than 2 kg Emile A Bacha, MD, Melvin Almodovar, MD, David L Wessel, MD, David Zurakowski,

Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection Bing-sheng Sun, MD, PhD, Yue.

Periodic pharyngolaryngoscopy detects early head and neck cancer and improves survival in esophageal cancer Akihito Watanabe, MD, Masao Hosokawa, MD,

The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non–small cell lung cancer Kyong-Ah Yoon,

Esophageal Resection for Cancer of the Esophagus: Long-Term Function and Quality of Life Allison J McLarty, MD, Claude Deschamps, MD, Victor F Trastek,

Clinical T2N0 Esophageal Cancer: Identifying Pretreatment Characteristics Associated With Pathologic Upstaging and the Potential Role for Induction Therapy

Survival after resection of synchronous non–small cell lung cancer

David T. Cooke, MD, Danh V. Nguyen, PhD, Ying Yang, MS, Steven L

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Pneumonectomy for stage i (T1N0 and T2N0) nonsmall cell lung cancer has potent, adverse impact on survival Christos Alexiou, FRCS, David Beggs, FETCS,

Factors predicting patterns of recurrence after resection of N1 non-small cell lung carcinoma Timothy E Sawyer, MD, James A Bonner, MD, Perry M Gould,

Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K

Combined Resection of Superior Vena Cava for Lung Carcinoma: Prognostic Significance of Patterns of Superior Vena Cava Invasion Kenji Suzuki, MD, Hisao.

Survival of Patients With or Without Symptoms Undergoing Potentially Curative Resections for Primary Lung Cancer Andrea R.G. Sheel, BS (Hons), MBChB,

Pulmonary Resection in the Treatment of Multidrug-Resistant Tuberculosis: A Retrospective Study of 56 Cases Haifeng Wang, MM, Hongsheng Lin, MM, Gening.

Trevor Williams, MD, MPH, Brian C

Surgical treatment of non-small cell lung cancer 1 cm or less in diameter Daniel L Miller, MD, Charles M Rowland, MS, Claude Deschamps, MD, Mark S Allen,

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Impact of Lepidic Component Occupancy on Effects of Adjuvant Chemotherapy for Lung Adenocarcinoma Shinsuke Sasada, MD, PhD, Yoshihiro Miyata, MD, PhD,

Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival Pamela Samson, MD, MPHS, Traves.

Prognostic factors in clinical stage I non–small cell lung cancer

Early pulmonary resection for localized mycobacterium avium complex disease Yuji Shiraishi, MD, Kanae Fukushima, MD, Hikotaro Komatsu, MD, Atsuyuki Kurashima,

Mechanical Pleurodesis Does Not Reduce Recurrence of Spontaneous Pneumothorax: A Randomized Trial Xianjun Min, MS, Yuqing Huang, MD, Yingshun Yang, MD,

Use of Amiodarone After Major Lung Resection

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Andrew P. Dhanasopon, MD, Michelle C. Salazar, MD, Jessica R

Felix G. Fernandez, MD, Onkar Khullar, MD, Seth D

Short-course induction chemoradiotherapy with paclitaxel for stage III non-small-cell lung cancer Thomas W Rice, MD, David J Adelstein, MD, Jay P Ciezki,

Eric S. Weiss, MD, MPH, Jeremiah G. Allen, MD, Christian A

Phase II Study of the Histone Deacetylase Inhibitor Romidepsin in Relapsed Small Cell Lung Cancer (Cancer and Leukemia Group B 30304) Gregory A. Otterson,

Pulmonary Resection for Lung Cancer in Octogenarians

Sublobar Resection Provides an Equivalent Survival After Lobectomy in Elderly Patients With Early Lung Cancer Jiro Okami, MD, PhD, Yuri Ito, PhD, Masahiko.

Yuji Tachimori, MD, Hoichi Kato, MD, Hiroshi Watanabe, MD

It’s All in the “Swerve of the Curve”

The Influence of Physician and Patient Gender on Risk Assessment for Lung Cancer Resection Mark K. Ferguson, MD, Megan Huisingh-Scheetz, MD, MPH, Katherine.

Resection of adrenal metastases from non-small cell lung cancer: a multicenter study Henri Porte, MD, PhD, Joëlle Siat, MD, Benoit Guibert, MD, Francoise.

Adhering to Quality Measures in Esophagectomy Is Associated With Improved Survival in All Stages of Esophageal Cancer Pamela Samson, MD, MPHS, Varun.

A Phase II Study of Carboplatin, Etoposide, and Exisulind in Patients with Extensive Small Cell Lung Cancer: CALGB 30104 Ramaswamy Govindan, MD, Xiaofei.

James D Luketich, Michael E Burt The Annals of Thoracic Surgery

Resected Synchronous Primary Malignant Lung Tumors: A Population-Based Study Hans Rostad, MD, PhD, Trond-Eirik Strand, MD, Anne Naalsund, MD, Jarle Norstein,

Prolonged Intensive Care Unit Stay in Cardiac Surgery: Risk Factors and Long-Term- Survival Ortrud Vargas Hein, MD, Jürgen Birnbaum, MD, Klaus Wernecke,

Prognostic Heterogeneity in Multilevel N2 Non-Small Cell Lung Cancer Patients: Importance of Lymphadenopathy and Occult Intrapulmonary Metastases Yukinori.

Effects of Delayed Surgical Resection on Short-Term and Long-Term Outcomes in Clinical Stage I Non-Small Cell Lung Cancer Pamela Samson, MD, Aalok Patel,

Neal S Goldstein, MD The Annals of Thoracic Surgery

Clinical Outcome After Pulmonary Resection for Lung Cancer Patients on Hemodialysis Toshiro Obuchi, MD, Wakako Hamanaka, MD, Yasuhiro Yoshida, MD, Jun.

Yangfeng Tang, MD, Zilin Liao, MD, Lin Han, MD, Zhiyun Xu, MD

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Mark I. Block, MD The Annals of Thoracic Surgery

Phase I Study of Induction Chemotherapy and Concomitant Chemoradiotherapy with Irinotecan, Carboplatin, and Paclitaxel for Stage III Non-small Cell Lung.

Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Tomas Gudbjartsson,

Preoperative chemotherapy for esophageal cancer with paclitaxel and carboplatin: results of a phase II trial R.S Keresztes, MD, J.L Port, MD, M.W Pasmantier,

Presentation transcript:

Sex-associated differences in survival of patients undergoing resection for lung cancer Mark K Ferguson, MD, Jun Wang, MD, Philip C Hoffman, MD, Daniel J Haraf, MD, Jemi Olak, MD, Gregory A Masters, MD, Everett E Vokes, MD The Annals of Thoracic Surgery Volume 69, Issue 1, Pages 245-249 (January 2000) DOI: 10.1016/S0003-4975(99)01078-4

Fig 1 Kaplan-Meier survival curves according to stage for patients who underwent major lung resection for lung cancer. Vertical hatch marks represent censored data points. Error bars represent 95% confidence intervals. The Annals of Thoracic Surgery 2000 69, 245-249DOI: (10.1016/S0003-4975(99)01078-4)

Fig 2 Kaplan-Meier survival curves for all stages combined for men and women who underwent major lung resection for lung cancer. Vertical hatch marks represent censored data points. Error bars represent 95% confidence intervals. Numbers at bottom indicate patients available for evaluation at each time point. (M = men; W = women.) The Annals of Thoracic Surgery 2000 69, 245-249DOI: (10.1016/S0003-4975(99)01078-4)

Fig 3 Kaplan-Meier survival curves according to stage (A, Stage I; B, Stage II; and C, Stage III) for men and women who underwent major lung resection for lung cancer. Vertical hatch marks represent censored data points. Error bars represent 95% confidence intervals. Numbers at bottom indicate patients available for evaluation at each time point. (M = men; W = women.) The Annals of Thoracic Surgery 2000 69, 245-249DOI: (10.1016/S0003-4975(99)01078-4)